Table 1.
Studies Included
| Study | Level of Evidence | n (Auto, Allo) | Patient Age (Auto, Allo), y (Range) | Follow-up, mo (Range) | Sex, % Male |
|---|---|---|---|---|---|
| Bottoni et al., 201520 | I | 48, 49 | 28.9, 29.2 (20.6-42.5) | 126 (120-132) | 86.6 |
| Noh et al., 201122 | I | 33, 32 | 23.0, 22.0 (20-55) | 29.8 (NR) | 86.2 |
| Yoo et al., 201725 | I | 68, 64 | 30.0, 24.0 (13-62) | 33.6 (25.3-59.5) | 90.9 |
| Edgar et al., 200829 | II | 37, 46 | 27.0, 31.0 (15-55) | 49.8 (36.0-74.0) | 55.4 |
| Lawhorn et al., 201221 | II | 74, 73 | 32.0, 33.3 (16-53) | NR | 68.0 |
| Maletis et al., 201732 | II | 4,557; 155 | NR | NR | NR |
| Maletis et al., 201733 | II | 10,264; 729 | NR | NR | NR |
| Sun et al., 20099 | II | 33, 34 | 29.7, 31.8 (19-64) | 30.8 (NR) | 68.7 |
| Sun et al., 201123 | II | 91, 95 | 29.6, 31.2 (18-59) | 94.8 (72-120) | 80.1 |
| Tian et al., 201624 | II | 62, 59 | 30.5, 29.9 (15-56) | 55.2 (48-66) | 79.3 |
| Barber et al., 201427 | III | 53, 28 | 18.6, 20.1 (13-25) | 34.0 (24-132) | 49.4 |
| Barrett et al., 200528 | III | 25, 38 | 44.5, 47.1 (40-58) | NR | 55.6 |
| Guo et al., 201212 | III | 41, 33 | 25.0, 25.3 (16-40) | 80.4 (50.4-98.4) | 63.5 |
| Kane et al., 201630 | III | 60, 59 | 19.8, 20.6 (NR) | NR | NR |
| Kustos et al., 200431 | III | 26, 53 | 24.5, 25.6 (NR) | 38.0 (NR) | 75.9 |
| Peterson et al., 200134 | III | 30, 30 | 25.0, 28.0 (15-55) | 63.6 (55-78) | 55.0 |
NOTE. n refers to the number of knees that underwent ACL reconstruction with either autograft or nonirradiated allograft in each study. Patient age and follow-up are reported as mean (range).
ACL, anterior cruciate ligament; Allo, nonirradiated allograft; Auto, autograft; NR, not reported.